Church & Dwight is the leading global producer of baking soda... Show more
In recent weeks, Church & Dwight (CHD) stock has demonstrated resilience within the consumer staples sector, balancing year-to-date advances with modest pullbacks in recent trading sessions. Shares have held steady above key technical levels, reflecting sustained investor interest as the company approaches its quarterly earnings. Broader market cycles in household and personal care products have introduced some volatility, yet CHD's positioning benefits from defensive qualities and growth narratives. Volume patterns indicate consistent engagement, positioning the stock for potential catalysts in the latest market cycle.
Tickeron’s Trending AI Robots page curates over 25 elite AI trading bots from a comprehensive library of 351 bots designed for copy trading across stocks, ETFs, and cryptocurrencies. These bots trade thousands of tickers using diverse strategies such as swing trading, pattern recognition, and momentum plays, spanning short-term day trades to longer-term positions. Selected for superior performance in current market conditions, they highlight adaptability to volatility and sector rotations, with many showcasing strong risk-adjusted metrics to appeal to varied investor profiles. Whether focusing on growth sectors or defensive plays, the trending selection empowers users with automated, data-driven signals. Explore the Trending AI Robots page to identify bots aligning with your trading style.
In the past 30 days, Church & Dwight (CHD) stock has experienced mixed price action, with shares pulling back modestly from recent highs amid pre-earnings positioning and analyst commentary. Trading in the mid-$90s range, the stock reflects caution as investors await the May 1 Q1 2026 earnings report, where analysts project EPS of $0.93 and revenue of approximately $1.47 billion. Positive Earnings Surprise Prediction (ESP) of +1.01% suggests potential for another beat, building on the company's history of exceeding estimates, as seen in Q4 2025's adjusted EPS of $0.86 versus $0.84 expected.
Analyst activity has influenced sentiment, with JPMorgan lowering its price target to $98 from $100 while maintaining a neutral rating on April 17, citing valuation pressures despite solid fundamentals. Overall, 23 analysts rate CHD as overweight or better, with an average target of $103.12, implying about 7% upside from recent levels. This consensus underscores confidence in the company's 2026 outlook but highlights near-term scrutiny on revenue acceleration.
On March 25, Church & Dwight announced a webcast for its Q1 results discussion, heightening anticipation and contributing to steady trading volumes. The stock's slight decline over the last month—down around 1-2%—aligns with broader consumer staples softness, where domestic volume challenges persist despite international strength. A Seeking Alpha analysis on April 20 flagged execution risks in the new evergreen strategy targeting 4% organic growth through 2030, pressuring shares amid competitive headwinds.
Macroeconomic factors, including persistent inflation in household essentials and shifting consumer spending, have tempered enthusiasm, yet CHD's defensive portfolio—bolstered by prior moves like the 2025 Touchland acquisition for $700 million and divestiture of VitaFusion and L'il Critters—supports stability. These developments have kept price action range-bound, with dips viewed as buying opportunities by some, setting the stage for earnings to dictate the next move.
Church & Dwight enters 2026 with a clear growth roadmap, guiding for 3-4% organic sales and 5-8% adjusted EPS growth, led by volume gains across divisions and momentum from the Touchland hand sanitizer brand. Investors should monitor integration success of recent acquisitions, innovation pipelines including new TheraBreath oral care products and Arm & Hammer cat litter enhancements, and performance in high-margin personal care segments.
Key risks include domestic consumption softness amid economic uncertainty, potential margin pressures from input costs, and intensifying competition in consumer staples. Opportunities lie in international expansion, e-commerce penetration, and portfolio streamlining to focus on premium brands. Regulatory scrutiny on product claims and supply chain resilience will also warrant attention. Balanced against these, the company's track record of margin expansion and dividend growth positions it to navigate sector headwinds effectively throughout the year.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
The Moving Average Convergence Divergence (MACD) for CHD turned positive on June 09, 2026. Looking at past instances where CHD's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 12, 2026. You may want to consider a long position or call options on CHD as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
CHD moved above its 50-day moving average on June 05, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CHD crossed bullishly above the 50-day moving average on May 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CHD advanced for three days, in of 344 cases, the price rose further within the following month. The odds of a continued upward trend are .
CHD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CHD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.522) is normal, around the industry mean (27.150). P/E Ratio (32.092) is within average values for comparable stocks, (56.431). Projected Growth (PEG Ratio) (3.045) is also within normal values, averaging (2.836). CHD has a moderately low Dividend Yield (0.012) as compared to the industry average of (0.035). P/S Ratio (3.802) is also within normal values, averaging (2.404).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of sodium bicarbonate and sodium bicarbonate based products
Industry HouseholdPersonalCare